Dr. Ling Su named new DIA board president
DIA announced the appointment of Dr Ling Su as President of the DIA Board of Directors.
Dr. Su is Senior Vice President and Head of Development Greater China Region of Beijing Novartis Pharma Co., Ltd. He is also an adjunct professor in the School of Pharmacy at Fudan University in Shanghai. Dr. Su brings more than 20 years of experience to DIA, specifically in the areas of regulatory affairs, clinical research and development, R&D strategies, pharmacovigilance, pharmacoepidemiology, and outcomes research.
Dr. Su has served as chair of the DIA Provisional Advisory Council of China and received the DIA Outstanding Service Award in 2000.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.